Abstract: Disseminated tuberculosis remains a diagnostic challenge because the presentations are nonspecific. In the current retrospective study we describe the clinical characteristics and outcome of disseminated tuberculosis. From January 1995 to December 2004, patients with culture-confirmed tuberculosis who fulfilled the criteria for disseminated tuberculosis were selected and their medical records reviewed. Their clinical isolates were genotyped. Of the 3058 patients with culture-confirmed tuberculosis, 164 (5.4%) had disseminated disease; 14.0% of patients had acquired immunodeficiency syndrome. The most common radiographic finding was miliary lung lesions (47.0%); 31.1% of patients died at the end of the study. Poor prognostic factors included hypoalbuminemia, hyperbilirubinemia, renal insufficiency, and delayed antituberculosis treatment. Clinical findings suggestive of disseminated tuberculosis were miliary lung lesions, serum ferritin >1000 mg/L, infiltrative liver disease, and adjusted calcium >2.6 mmol/L. Simultaneously performing mycobacterial culture and histopathologic examination of bone marrow biopsy was more sensitive and faster than just performing mycobacterial blood culture in diagnosing disseminated tuberculosis. Of the 64 preserved Mycobacterium tuberculosis isolates, 47 (73.4%) were clustered and 27 (42.2%) were Beijing family. Since prognosis was worse in patients with delayed treatment, a high index of suspicion is required, especially in those with clinical findings suggestive of disseminated tuberculosis.
INTRODUCTION
A lthough extrapulmonary tuberculosis (TB) had been observed for many centuries, the exact incidence of disseminated TB is still unclear. Disseminated TB is defined as tuberculous infection involving the blood stream, bone marrow, liver, or 2 or more noncontiguous sites, or miliary TB 2, 22 . The symptoms are nonspecific and the duration of symptoms before diagnosis is variable 7, 16, 18, 20, 22, 26 . Therefore, it mimics a variety of diseases and requires a high index of suspicion. Of all cases of disseminated TB found at autopsy, 33%-80% were missed antemortem 28 . Moreover, previous studies revealed that misdiagnosis leading to a treatment delay of a mere 1-8 days contributes to a high mortality rate 4, 9, 30 . Therefore, we conducted the current study to describe the clinical characteristics and outcome of patients with disseminated TB.
PATIENTS AND METHODS
The current study was conducted in a 1500-bed, tertiary-care referral center in northern Taiwan. Disseminated TB was diagnosed if the patient had any of the following conditions: 1. Isolation of Mycobacterium tuberculosis from blood, bone marrow, liver biopsy specimen, or 2 noncontiguous organs 5 ; 2. Isolation of M. tuberculosis from 1 organ and histologic demonstration of caseating granulomatous inflammation from the bone marrow, liver biopsy specimen, or another noncontiguous organ; 3. Isolation of M. tuberculosis from 1 organ and radiographic finding of miliary lung lesions 2, 22 . A patient with isolated tuberculous hepatic abscess or tuberculoma rather than diffuse hepatic involvement was not included in the study 1 . The dual sites involvement of cervical lymph node and lung was regarded as a loco-regional disease rather than disseminated disease 34 . We searched the mycobacterial laboratory and histology databases from January 1995 to December 2004. Those who fulfilled the criteria for disseminated TB were included and their medical records reviewed. Preserved isolates of M. tuberculosis from those patients were subcultured on Lowenstein-Jensen media, incubated at 37 8C in an aerobic atmosphere with 5%-10% CO 2 , and genotyped using spoligotyping after 1996, Middlebrook 7H11 selective agar with antimicrobials (Remel Inc., Lexena, KS) was added. The fluorometric BACTEC technique (BACTEC Mycobacterium Growth Indicator Tube [MGIT] 960 system, BectonDickinson, Sparks, MD) was added after July 1998. Serum calcium level was adjusted by adding 0.2 mmol/L for every 1 g/dL decrease of serum albumin below 4 g/dL 25 . Infiltrative liver disease was defined if serum alkaline phosphatase (ALP) was elevated to >440 U/L (normal = <220 U/L) with elevated serum gamma glutamyltransferase (GGT) level (normal = <53 U/L) or GGT >106 U/L. Standard antituberculosis treatment consisted of isoniazid, ethambutol, rifampicin, and pyrazinamide (HERZ) in the 2-month induction phase and HER in the maintenance phase, and was modified according to the presence of hepatic and/or renal disease, adverse effects, and the results of drug susceptibility testing after it became available. In patients with liver disease, pyrazinamide may be omitted. The maintenance phase was 4 months in general, but was prolonged to 7 months in patients with skeletal involvement. Multidrug-resistant TB, defined as TB simultaneously resistant to isoniazid and rifampicin, was treated for at least 18 months. The antituberculosis treatment was considered early if started within 14 days after the initial visit, and was judged as completed if fulfilling the definition of the World Health Organization 33 . All deaths were either identified by reviewing the medical records in our hospital or captured through the National Surveillance Network of Communicable Disease (Centers for Disease Control, Taiwan). All patients were followed-up until completely treated, died, or until June 2005 (end of the study).
Intergroup differences were analyzed using either the ANOVA (continuous variables) or chi-square test (categorical variables). One-year survival curves for each variable with possible prognostic significance were generated using the Kaplan-Meier method and were compared using the logrank test. If a significant difference (p < 0.05) was reached, the variables then entered the multivariate survival analysis using the stepwise forward Cox regression to identify factors independently associated with mortality.
RESULTS
From January 1995 to December 2004, a total of 3058 patients with culture-confirmed TB were identified. Of these, 164 (5.4%) fulfilled the diagnostic criteria for disseminated TB. Laboratory tests for human immunodeficiency virus (HIV) were performed in 157 (95.7%) patients. Eighty-seven (53.0%) patients had underlying comorbid conditions, the most common being acquired immunodeficiency syndrome (AIDS) (23 patients, 14.0%) and diabetes mellitus (23 patients, 14.0%), followed by malignancy (16 patients, 9.8%), end-stage renal disease (ESRD) (14 patients, 8.5%), liver cirrhosis (11 patients, 6.7%), status post-transplantation (6 patients, 3.7%), autoimmune disease (5 patients, 3.0%), and alcoholism (3 patients, 1.8%). In the 23 AIDS patients, CD4 count was available for 18 (78.3%). The median CD4 count was 38 mL (range, 2-135 mL). Kaplan-Meier survival analysis revealed that the underlying comorbid condition (HIV/AIDS vs. other comorbidities vs. no comorbidities) was significantly associated with prognosis (p = 0.002) (Figure 1 ). The most commonly involved organs were the lungs (143 patients, 87.2%) and musculoskeleton (32 patients, 19.5%), followed by the urogenital system (28 patients, 17.1%). HIV/AIDS patients had a higher incidence of mycobacteremia (30.4%) and bone marrow involvement (39.1%) ( Table 1) . TB peritonitis or pericarditis was more common in patients with underlying diseases other than HIV/ AIDS (23.4%).
Fourteen (8.5%) and 5 (3.0%) M. tuberculosis isolates were resistant to isoniazid and rifampicin, respectively. All rifampicin-resistant isolates were also multidrug resistant. Significantly more patients in the HIV/AIDS group received antituberculosis treatment at an early stage than patients in the other 2 groups (p = 0.015, see Table 1 ). The most common radiographic findings on chest images were miliary lesions (47.0%) and consolidation (32.3%). The former was more common in the HIV/AIDS (69.6%) group, whereas the latter was usually seen in patients with other comorbid conditions (42.2%). Only 4.9% of patients with disseminated TB had mainly fibrotic change on their chest images. Cavitation was also rare (2.4%).
The most common abnormal laboratory findings were hypoalbuminemia (74.7%) (normal = >3.5 g/dL), elevated GGT (71.0%) (normal = <53 U/L), and ALP (66.4%) (normal = <220 U/L), followed by hyponatremia (58.9%) (normal = <135 mmol/L) and anemia (43.9%) (normal = >10 g/dL) ( Table 2 ). Elevated aspartate aminotransferases (normal = 40 U/L), alanine aminotransferases (normal = 40 U/L), and total bilirubin (normal = 1.0 mg/dL) were found in 37.0%, 20.8%, and 25.5%, respectively. Patients with underlying comorbid conditions other than HIV/AIDS had most abnormal results. Hypercalcemia (adjusted calcium >2.6 mmol/L) was noted in 22 patients (13.4%), including 7 with ESRD and 5 with malignancy. None of them received vitamin D supplementation. Of them, serum phosphate and intact parathyroid hormone levels were available in 20 and 7, respectively. The average phosphate level was 5.1 mg/dL (range, 2.6-9.5; normal = 3-4.5 mg/dL), while intact FIGURE 1. Survival curves for patients with different underlying comorbid conditions, plotted using the Kaplan-Meier method. Black dots represent patients who were still alive at the end of the current study. The results of genotyping were available in only 63 patients. parathyroid hormone level was lower than normal in 6 patients and at the lower part of the normal range in the remaining 1 (mean, 6.9 pg/mL; range, 1-18.9 pg/mL; normal = 15-70 pg/mL). Of the 14 patients with ESRD, 1 had ever received iron supplement, and his serum ferritin level was normal (normal = male, 26.6-377 mg/L; female, 3.0-151 mg/L). Within 1 year of follow-up, 99 (60.4%) patients were completely treated, 51 (31.1%) died, 10 (6.1%) were under treatment, and 4 (2.4%) were lost. Twenty-three (14.0%) patients died of TB. The cause of death was M. tuberculosis septic shock with multiorgan failure in 15 and respiratory failure due to extensive pulmonary damage in 8. In the remaining 28 mortalities, septic shock due to pathogens other than M. tuberculosis was responsible for 14 mortalities. Another 7 patients died of respiratory failure, including extensive pulmonary damage in 4 and sputum impaction in 3. Another 3 patients, including 2 patients with intracerebral hemorrhage and 1 with brain tumor, died of severe increased intracranial pressure. Three patients died of massive upper gastrointestinal bleeding. The cause of death in the remaining 1 was acute myocardial infarction. Serum levels of albumin, total bilirubin, and creatinine, and timing of antituberculosis treatment were independent prognostic factors in the multivariate Cox regression analysis ( Table 3 ). The clinical findings that suggested the diagnosis and could lead to early treatment of TB are listed in Table 4 . In fact, 73.5% of patients with early antituberculosis treatment had miliary pattern on chest radiograph, compared with only 19.8% of those with delayed treatment (p < 0.001). In the 164 patients with disseminated TB, at least 1 diagnostic clue was present in 116 (70.7%).
Specimens submitted for mycobacteriologic studies and the results are summarized in Table 5 . Data were aggregated by patient and sample type. For example, if 1 of the sputum samples was positive, then the results of sputum culture were recorded as positive. The culture yield rates of sputum (97.1%), lymph node (100%), and synovial fluid (92.3%) were the highest. The most common biopsy sites were bone marrow, followed by lymph node ( Table 6 ). The highest were from the testis (100%), joint (100%), and lymph nodes (92.0%). The yield rate of histopathologic examination for bone marrow was 44.7%. Fifteen bone marrow samples were submitted for both mycobacterial culture and histopathologic examination. Five were positive in both tests, another 6 were culture-positive, and another 3 were histopathologically positive. The diagnostic rate of the combined mycobacterial culture and histopathologic examination for TB was 93.3%.
The clinical isolates of M. tuberculosis were available in 64 patients, including 9 HIV/AIDS patients, 25 with other underlying comorbid condition, and 30 previously healthy patients. Genotyping revealed that 47 (73.4%) isolates belonged to 5 clusters and the remaining 17 (26.6%) isolates had unique patterns. Beijing family was the largest cluster and consisted of 27 (42.2%) clinical isolates (see Table 1 ).
DISCUSSION
Disseminated TB is a potentially lethal form of TB resulting from massive lymphohematogenous dissemination of M. tuberculosis bacilli. The emergence of the HIV/AIDS pandemic and widespread use of immunosuppressive drugs has change the epidemiology of disseminated TB 8, 23 . Impaired cell-mediated immunity underlies the disease's development. Clinical manifestations are nonspecific, and typical chest radiographic findings may not be seen 11, 17 . Systematic data collection and reporting to study the epidemiology and prognosis of disseminated tuberculosis is lacking. In addition, the diagnostic approach has not been standardized 24 . Of patients with culture-confirmed TB, 5.4% were disseminated. The percentages of patients with underlying diseases were much lower than previously reported 5 , reflecting the high incidence of TB (62.4 per 100,000 population in 2003) and relatively low incidence of HIV/ AIDS in Taiwan (1.3 per 10,000 population in 2004). The clinical characteristics were very different among patients with different underlying comorbid conditions. Factors associated with poor prognosis included albumin <3.5 g/dL, total bilirubin >1.0 mg/dL, creatinine >1.5 mg/dL, and delayed antituberculosis treatment.
Of the factors that were associated with prognosis, most (albumin, bilirubin, creatinine levels) reflect the severity of TB or underlying diseases. One (early treatment) directly reflects the importance of a timely, correct diagnosis. The HIV/AIDS group had the highest rate of early treatment, while the group with other underlying diseases had the lowest (see Table 1 ), which partially contributed to its poorest outcome (in univariate analysis). Factors leading to delayed diagnosis and treatment in this group include the following: 1) Patients in this group had pleura, peritoneum, or pericardium as the most common sites of extrapulmonary involvement (23.4%). Because pleuro-pericardial effusions and ascites are common in such patients (with coexisting ESRD, malignancy, liver cirrhosis) even without concomitant TB, the diagnosis of TB in this group is difficult and often delayed. 2) Although the yields of pleural (55.6%) or peritoneal fluids (70.0%) culture were high, the prolonged culture time offsets their usefulness.
3) The high yields of pleural (61.5%) and peritoneal (85.7%) biopsy could be helpful in making a quick diagnosis, although the bleeding tendency in patients with ESRD or liver cirrhosis often prohibits such procedures. 4) This group had the lowest rate of miliary pattern (37.5%) on chest radiograph, which lowered clinical suspicion of TB 17 . The group with HIV/ AIDS, on the contrary, had the highest rate of miliary TB (nearly 70%), which helped early diagnosis and treatment. 5) Even when TB is highly suspected, the presence of renal and/or hepatic insufficiency in these patients often prevents the empirical use of antituberculosis chemotherapy.
Consistent with previous reports 5 , patients with disseminated TB usually had several abnormal laboratory findings, showing hypoalbuminemia, elevated ALP and GGT, hyponatremia, and anemia (see Table 2 ). The laboratory data reflect malnutrition, infiltrative liver disease, inappropriate secretion of antidiuretic hormone, and chronic illness, respectively. Previous study of disseminated TB also showed that 80% of patients had pathologic evidence of hepatic involvement, and presented with elevated ALP and GGT with only slight increases of hepatic transaminases and bilirubin 23 , suggesting infiltrative liver disease such as TB, rather than chronic active hepatitis, cirrhosis, or hepatic congestion 13 . We also found that one-sixth of our patients had serum ferritin >1,000 mg/L (see Table 4 ); a previous report also showed the association of hyperferritinemia with miliary TB 3 . Though the cause of hyperferritinemia was not certain, it most likely came from chronic systemic infection 3, 27, 32 . Hypercalcemia was detected in 13.4% of the patients with disseminated TB and 18.8% of those with underlying comorbid conditions other than HIV/AIDS. The concomitant high serum phosphate and low parathyroid hormone suggested a vitamin D-dependent pathophysiology rather than malignancy or hyperparathyroidism. Because none of our patients received vitamin D supplementation, the vitamin D-dependent hypercalcemia was most likely due to granulomatous disease 6, 10 . The absence of hypercalcemia in HIV/AIDS patients probably implied a weakened host immunity and failure to mount a granulomatous inflammation. We found that certain laboratory abnormalities often were associated with disseminated TB: elevated ALP or GGT, serum ferritin >1,000 mg/L, and hypercalcemia. Although these clinical clues are difficult to assess since the specificity of all factors, except miliary lung lesions, is low, they could raise the suspicion of disseminated TB.
Two previous reports 15, 29 comparing the clinical utility of bone marrow biopsy and culture with blood cultures for mycobacterial infection among HIV/AIDS patients showed that the yields were similar and their results were highly concordant (75%-83.7%), suggesting that the combined use of both studies would provide the maximum diagnostic yield. Because of the added cost, patient discomfort, and the risk of needle stick to the operator during bone marrow studies, routine blood culture was recommended during evaluations for mycobacterial infections in HIV/AIDS patients 15, 29 . However, most of the disseminated mycobacterial diseases in the 2 studies were due to Mycobacterium avium complex (78.2%), rather than M. tuberculosis. In addition, the bone marrow biopsy usually provided the first positive result in the majority of these patients. In the first patient series that we know of to assess the sensitivity of blood culture and bone marrow culture for the diagnosis of disseminated TB, Crump et al 5 found that mycobacterial blood culture was as sensitive as bone marrow culture (58% vs. 54%), and recommended performing mycobacterial blood culture instead of bone marrow culture when disseminated TB was suspected. However, histopathologic examination of bone marrow was not assessed in that study. In the current series, the sensitivity of bone marrow studies for disseminated TB (mycobacterial culture: 64.7%, histopathologic examination: 44.7%, combined: 93.3%) was much higher than that of mycobacterial blood culture (38.5%). The lower yield rate of blood culture (38.5% vs. 58%) reflects the smaller proportion of HIV/AIDS patients in the current study (14.0% vs. 46%). In addition, bone marrow biopsy findings of caseating granulomatous inflammation characteristic of TB can be obtained within days, allowing antituberculosis treatment to be started early. The biopsy procedure is safer than liver, pleural, or peritoneal biopsy for patients with renal or hepatic insufficiency and bleeding tendency. Thus, bone marrow biopsy can be valuable in the early diagnosis of disseminated TB.
A major goal of molecular epidemiologic studies of TB is to use molecular methods (DNA fingerprinting) to distinguish between reactivation and recent transmission. The fingerprints of each isolate are classified as clustered (that is, sharing a fingerprint with another isolate in the study sample) or unique. Most researchers interpret clusters to be epidemiologically linked chains of recent transmitted disease, and unique to be isolates that are cases of reactivation disease resulting from ''remote'' M. tuberculosis infection 19, 21 . Compatible with a previous study in the general TB population in Taiwan which showed 24.8% clustered pattern among 113 resolved genotypes 12 , we found 22.7% of the resolved genotypes had clustering patterns and accounted for about threefourths of the clinical isolates. To our knowledge, no studies have suggested any certain genotype to be ''disseminationprone.'' Our findings imply that some genotypes are dominant, and recent transmission may be important among patients with disseminated TB in Taiwan. However, only 39% of our isolates were genotyped, and we don't have contact history to support our speculation.
The current study was limited by its retrospective nature; studies for disseminated TB were not routinely performed. Thus the incidence might be underestimated. Many of the laboratory studies listed in Table 2 , as well as the ''diagnostic clues,'' were not routinely performed in TB patients with localized disease, especially in those with pure pulmonary involvement. Therefore, the comparison between disseminated disease and localized disease to assess the diagnostic clues was difficult. Furthermore, in the absence of postmortem examination, it is possible that only the most ill patients were biopsied and cultured. Prospective studies are necessary to clarify these issues.
In conclusion, 5.4% of the patients with cultureconfirmed TB had disseminated disease. Half of them had underlying comorbid conditions. About three-fourths of the M. tuberculosis isolates showed clustering patterns, suggesting that recent transmission probably has a major contribution to disseminated TB in Taiwan. Poor prognostic factors include hypoalbuminemia, hyperbilirubinemia, renal n 2007 Lippincott Williams & Wilkins insufficiency, and delayed antituberculosis treatment. Clinical findings suggestive of disseminated TB are present in 70.7% of all patients. Combined mycobacterial culture and histopathologic examination of biopsy from bone marrow were more sensitive and faster than mycobacterial blood culture in diagnosing disseminated TB.
